University of California San Francisco
Helen Diller Family Comprehensive Cancer Center

Funding Opportunities

[ LSOs | Intramural Awards | Foundations/Other | NIH Announcements ]

Limited Submission Opportunities

(Applications through LSO office)


Intramural Funding Opportunities

Foundations/Other Sources

  • LOI Deadline: Sep 1
    SU2C Health Equity Breakthrough Team Research Grant Program

    The Breakthrough Team represents an unprecedented opportunity to bring together the best scientific minds from diverse fields of research to concentrate on new approaches to address health equity in the context of cancer research.
  • LOI Deadline: Sep 9
    NCCN/Pfizer Request for Proposals (RFP) Adoption of Biosimilars in Oncology

    The National Comprehensive Cancer Network® (NCCN) and Pfizer Global Medical Grants (Pfizer) are collaborating to offer a new grant opportunity seeking proposals in support of the adoption of biosimilars in oncology. Seeking proposals describing concepts and ideas that develop and validate enduring approaches that improve the safe and efficient adoption of biosimilars in oncology. Proposals that directly measure increases in biosimilar use or improve safety, value and efficiency in oncology practices will be prioritized. The sustainability and broad applicability of the approach will be key factors in evaluating funded projects.  

NIH Announcements

To view all NCI funding opportunities, search here